ENAVATE SCIENCES GP, LLC: 13F holdings
CIK 19531072026Q2
| Positions | 7 |
|---|---|
| Reported value | $345.4m |
| Filed | 2026-08-14 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| SIONNA THERAPEUTICS INC | 2,478,030 | $109.0m | 31.6% |
| ZENAS BIOPHARMA INC | 3,919,159 | $99.5m | 28.8% |
| IMMUNOME INC | 3,613,799 | $76.6m | 22.2% |
| BRIDGEBIO ONCOLOGY THERAPEUT | 2,626,946 | $20.0m | 5.8% |
| COMPASS THERAPEUTICS INC | 7,788,150 | $17.1m | 4.9% |
| UPSTREAM BIO INC | 2,459,703 | $17.0m | 4.9% |
| CAMP4 THERAPEUTICS CORP | 1,425,541 | $6.2m | 1.8% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1953107")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.